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ABSTRACT
The purpose of this report is to evaluate the association between lower genital tract inflammation
and objectively diagnosed endometritis. We analyzed the first 157 patients enrolled in the PEACH
study, a multicenter randomized clinical trial designed to compare the effectiveness of outpatient
and inpatient therapy for PID. Women less than 38 years of age, who presented with a history of
pelvic discomfort for 30 days or less and who were found to have pelvic organ tenderness (uterine
or adnexal tenderness) on bimanual examination, were initially invited to participate. After recruit-
ment of the first 58 patients (group 1) we added the presence ofleukorrhea, mucopurulent cervicitis,
or untreated positive test for N. gonorrhoeae or C. trachomatis to the inclusion criteria (group 2, N
99). We compared rates ofendometritis in the two groups and calculated the sensitivity, specificity,
and predicted values of the presence of white blood cells in the vaginal wet preparation. The rate of
upper genital tract infection in group 1 was 46.5% (27/58) compared to 49.5% (49/99) in group 2.
Microbiologic evidence of either N. gonorrhoeae or C. trachomatis increased from 22.4% in group 1
to 38.3% in group 2. The presence of Vaginal white blood cells or mueopus has a high sensitivity
(88.9%), but a low specificity (19.4%) for the diagnosis of upper genital-tract infection. Assessment
of the lower genital tract for evidence of infection or inflammation is a valuable component of the
diagnostic evaluation of pelvic inflammatory disease. The presence of either mucopus or vaginal
white blood cells is a highly sensitive test for endometritis in patients with pelvic pain and tender-
ness. Infect. Dis. Obstet. Gynecol. 8:83-87, 2000. (C) 2000 Wiley-Liss, Inc.
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elvic inflammatory disease (PID) causes more
morbidity and mortality to women between the
ages of 15 and 25 than all other infections com-
bined. In fact, PID affects almost 11% of United
States women during their reproductive years, e
The reproductive sequelae of PID can be devas-
tating and can include infertility, chronic pelvic
pain, ectopic pregnancy, and recurrent infec-
tions.3,4
The clinical diagnosis of PID is inaccurate. The
Centers for Disease Control and Prevention’s mini-
mal criteria for the diagnosis of PID have low sen-
sitivity and specificity,s,6 These criteria do not re-
liably discriminate infectious from other genital-
tract etiologies of pelvic pain. In the diagnostic
criteria for PID, the CDC lists "additional criteria"
which may improve the specificity of the diagnosis
in women who present with the "minimum crite-
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ria" for PID (abdominal tenderness, cervical mo-
tion tenderness, and adnexal tenderness). One of
the additional supportive criteria listed is the pres-
ence of abnormal cervical or vaginal discharge.7
The evaluation of vaginal discharge is one of the
most underutilized, yet consistent, predictors of
upper genital-tract infection. The largest cohort
study to date, in which Swedish women suspected
of having PID underwent a laparoscopic evalua-
tion, found that a marked increase in the number of
inflammatory cells (i.e., inflammatory cells out-
numbering all other cellular elements in the smear)
was associated with laparoscopic salpingitis.4 In ad-
dition, the absence of white blood cells in the vagi-
nal discharge plus clear cervical mucus is felt to
reliably exclude upper genital-tract infection (high
negative predictive value).8
The purpose of this preliminary report is to
evaluate the association between lower genital-
tract inflammation (mucopus or vaginal white
blood cells on saline microscopic preparation) and
objectively diagnosed upper genital-tract infection.
The hypothesis of this study is that evidence of
lower genital-tract inflammation is a sensitive test
in women presenting with pelvic pain and tender-
ness.
SUBJECTS AND METHODS
The PID Evaluation and Clinical Health (PEACH)
study, funded by the Agency for Health Care
Policy and Research, is a multicenter randomized
clinical trial designed to compare inpatient versus
outpatient antimicrobial therapy for the treat-
ment of PID. It is the largest prospective study of
PID ever conducted in North America, and the
first trial to evaluate the effectiveness and cost-
effectiveness of currently recommended antibiotic
regimens in terms of preventing long-term repro-
ductive sequelae.
The methods of the PEACH study have been
fully described in a prior publication,
9 so an abbre-
viated overview is provided here. Patients are re-
cruited from eight clinical sites (Charleston, Provi-
dence, Birmingham, Atlanta, Philadelphia, Pitts-
burgh, Detroit, and Dallas). Prior to recruitment,
the study was approved by the institutional review
board at each center. Women less than 38 years of
age who present with a history of pelvic discomfort
for 30 days or less and who are found to have pelvic
organ tenderness (uterine or adnexal tenderness)
on bimanual examination are invited to participate.
At the launch of the trial, these criteria were the
only inclusion criteria. If an initial review showed
that the rate of upper-tract infection in the cohort
was relatively low, we added the presence of one or
more of the following as inclusion criteria: (1) leu-
korrhea (finding more white blood cells than epi-
thelial cells in at least four high power fields of a
saline vaginal wet mount); (2) mucopurulent cervi-
citis (yellow or green mucus discharge from the
endocervix); and (3) untreated positive test for N.
gonorrhoeae or C. trachomatis from the cervix. These
additional criteria represented evidence of lower
genital-tract infection or inflammation. This
change in methodology provided an opportunity to
evaluate the association of lower genital-tract in-
flammation (mucopus or vaginal white blood cells)
and objective evidence of upper genital-tract infec-
tion. In the initial group recruited between Febru-
ary and May, 1996, (group 1), evidence of lower
genital-tract infection or inflammation was not part
of the inclusion criteria. In the subsequent group
recruited between June and October, 1996, (group
2), evidence of lower genital-tract inflammation or
positive test for N. gonorrhoeae or C. trachomatis was
required for patient inclusion in the study.
Women were excluded from participation for
the following reasons: (1) positive test for beta hu-
man chorionic gonadotropin; (2) inability to toler-
ate oral antibiotic therapy; (3) presence of a tubo-
ovarian abscess; (4) surgical emergency (e.g., ap-
pendicitis or suspected ovarian torsion) requiring
immediate operative intervention; (5) pain present
for more than 30 days; (6) severe allergy to peni-
cillins, cephalosporins, or tetracyclines; (7) antimi-
crobial therapy within seven days of presentation;
(8) delivery, abortion, or gynecologic surgery within
the last 30 days (9) prior hysterectomy or bilateral
salpingectomy; and (10) homelessness.
Baseline data collection included standard de-
mographic and reproductive characteristics, includ-
ing education, insurance, contraceptive use, douch-
ing, history of gynecologic infections and sexually
transmitted diseases, and sexual history. Clinical
data collected included degree and duration of
pain.
Baseline examination included pelvic examina-
tion and scoring of pelvic tenderness. Assessment
of vaginal discharge for presence of trichomonads,
bacterial vaginosis, and candidal infection was per-
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formed using microscopy of saline and potassium
hydroxide preparations. Vaginal fluid was also
tested for pH and release of amine odor with the
addition of potassium hydroxide (whiff test). A
vaginal gram stain was also performed. Bacterial
vaginosis was considered present when three out of
four clinical criteria for the diagnosis were obtained
as outlined by Amsel.1 Trichomonas was diag-
nosed by examining numerous high-power fields
for motile trichomonads.
After cleansing the ecto- and endocervix with
providone iodine, cervical swabs were obtained for
gram stain and for polymerase chain reaction (PCR)
testing for N. gonorrhoeae and C. trachomatis. An en-
dometrial biopsy was performed with a flexible
suction cannula and assessed by N. gonorrhoeae cul-
ture C. trachomatis PCR, and with histologic evalu-
ation. Blood samples were sent for white blood cell
count and erythrocyte sedimentation rate. Urinaly-
ses were obtained and were sent for culture when
suspicious. Because laparoscopy was not a feasible
method of evaluation for all participants, we used
histologic evidence of endometritis as the diagnos-
tic criteria for upper-tract infection. Histologic evi-
dence of acute or chronic endometritis was consid-
ered present when there was -> plasma cell in the
stroma and/or ->5 neutrophils in the endometrial
epithelium.11,e
We analyzed the baseline data from the first 157
patients enrolled in the PEACH study. We chose
this group as a relatively homogeneous sample, be-
cause after this time additional clinical sites were
added. Incorporating the additional clinical sites
would introduce site and patient characteristic vari-
ability. We stratified this pool into two groups: leu-
korrhea, mucopus, and positive evidence for cervi-
cal infection not required (group 1) and lower
genital-tract inflammation or infection as inclusion
criteria (group 2); and we evaluated the change in
the rate of upper genital-tract infection. Categorical
variables were analyzed by z tests. In group 1, we
then calculated the sensitivity, specificity, and pre-
dictive values of mucopurulent cervicitis and the
presence/absence of white blood cells in the vagi-
nal discharge from two-by-two tables. The 95%
confidence intervals of the diagnostic indices were
calculated from formula described by Snedecor and
Cochran.3 Diagnostic indices could not be calcu-
lated from group 2 since lower genital-tract inflam-
mation was an inclusion criteria in this group.
RESULTS
The demographic and reproductive characteristics
of the initial 157 patients stratified by group is
shown in Table 1. There were no significant dif-
ferences in demographic or reproductive character-
istics by group.
In group 1, the rate of upper genital-tract infec-
tion was 46.5% (27/58). After leukorrhea was added
to the inclusion criteria (group 2), the rate of upper-
tract infection was 49.5% (49/99). The percentage
ofwomen with microbiologic evidence of C. tracho-
matis increased from 8.6% in group to 17.4% in
group 2 (N 150). Microbiologic evidence of either
N. gonorrhoeae or C. trachomatis increased from
22.4% in group to 38.3% in group 2 (N 157).
Furthermore, N. gonorrhoeae and C. trachomatis were
isolated from the upper genital tract in 18.5% of
patients in group and from 25.3% of patients in
group 2. Mucopurulent cervical discharge was also
much more common in group 2 (31.0 vs. 57.6%).
The findings of an increased prevalence of posi-
tive tests for N. gonorrhoeae or C. trachomatis and
mucopurulent cervical discharge is expected since
these criteria were part of the inclusion criteria for
group 2.
The diagnostic test characteristics for the pres-
ence of either vaginal white blood cells or muco-
purulent cervicitis and the presence of both find-
ings are presented in Table 2. In group 1, the pres-
ence of vaginal white blood cells in the vaginal
discharge or mucopus has a high sensitivity (88.9%;
95% confidence interval (CI) 75.2%, 100%), but a
low specificity (19.4%; 95% CI 3.8%, 34.9%). In the
total cohort, the presence of either mucopus or
vaginal white blood cells had a sensitivity of 96.1%
(95% CI 91.0%, 100%).
DISCUSSION
The clinical interpretation of these results is as fol-
lows: the presence of lower genital-tract inflamma-
tion (either mucopus or white blood cells in the
vaginal discharge) is a sensitive test for upper geni-
tal-tract infection (histologic endometritis). In
other words, there are relatively few false negatives
(no mucopus and no vaginal white blood cells) in
patients with endometritis. Therefore, one should
suspect other causes of pelvic pain in a woman who
presents with pain and tenderness but is found to
have no white blood cells in the vaginal discharge
and no mucopus.
INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY 85LGI AND ENDOMETRITIS PEIPERTET AL.
TABLE I. Demographic and reproductive characteristics by group
Group Group 2 Total
(N 58) (N 99) (N 157)
Characteristic N % N % N % P value
Age
<20 19.0 24
20-24 22 37.9 36
25-29 13 22.4 20
30-34 9 15.5 14
>34 3 5.2 5
Race (N 157)
Black 38 65.5 65
White 12 20.7 16
Hispanic 3 5.2 14
Other/unknown 5 8.6 4
Marital status (N 146)
Never married 37 67.3 60
Separated 5 9. 10
Married/remarried 7 12.7 12
Divorced 5 9. 9
Widowed 1.8
Education
<high school diploma 26 44.8 36
>-high school diploma 32 55.2 63
Uninsured (N 145) 20 36.4 40
History of STD (N 156) 36 62.1 57
History of PID (N 156) 20 34.5 34
Trichomoniasis (N 157) 5 8.6 12
Bacterial vaginosis (N 155) 17 30.4 27
24.2 35 22.3 NS
36.4 58 36.9
20.2 33 21.0
14.1 23 14.6
5.1 8 5.1
65.7 103 65.6 NS
16.2 28 17.8
14.1 17 10.8
4.0 9 5.7
65.9 97 66.4 NS
1.0 15 10.3
13.2 19 13.0
9.9 14 9.6
0.7
36.4 62 39.5 NS
63.6 95 60.5
44.4 60 41.4 NS
58.2 93 59.6 NS
34.7 54 34.6 NS
12. 17 10.8 NS
27.3 44 28.4 NS
aSome data missing; percent based on known data.
TABLE 2. Sensitivity, specificity, and predictive
values of mucopurulent cervicitis and presence of
vaginal white blood cells for predicting upper
genital-tract infection
Either mucopus Both mucopus
Group or vaginal and vaginal
(N 58) WBCs (%) WBCs (%)
Sensitivity 88.9 51.9
Specificity 19.4 87.
Positive predictive value 49.0 77.9
Negative predictive value 66.7 67.5
Total Cohort (N 157)
Sensitivity 96. 61.8
Specificity 4.4 65.4
Positive predictive value 49.3 62.3
Negative predictive value 66.7 64.6
Evaluation for lower genital-tract inflammation
is one of the most valuable tests for the diagnosis of
upper genital-tract infection. Other studies have
shown that saline wet prep is one of the most sen-
sitive tests for the diagnosis of upper-tract infec-
tion. 14 The test is inexpensive and relatively easy
to perform.
This finding is consistent with results presented
from previous studies of diagnostic testing for
PID. is In a cohort of women evaluated for classic
and "non-classic" signs and symptoms of upper-
tract infection, Peipert and colleagues noted that
the evaluation of microscopic preparation for vagi-
nal white blood cells (WBCs) was the most sensi-
tive test for objective evidence of upper-tract in-
fection.4 The results of the present study differ
from the this previous study4 due to the different
inclusion criteria. All participants in the present
study had pelvic pain while subjects in the 1996
report
14 had a wider spectrum of symptoms. In the
largest cohort of suspected PID studied, Westrom
and colleagues noted that the combination of clear
cervical mucus and the absence of WBCs in the
vagina could reliably exclude PID in almost all
cases.8
This study goes beyond previous reports in the
literature evaluating lower genital-tract inflamma-
tion as a marker of upper-tract infection. As a mul-
ticenter clinical trial, this study is more readily be
generalized to U.S. populations than can the Swed-
ish cohort or other studies with recruitment limited
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to a specific geographic area. In addition, this study
includes patients that meet the CDC’s minimal
criteria for PID and patients who may not meet the
CDC criteria, but have more subtle signs of upper-
tract infection (i.e., any pelvic tenderness).
The limitations of this report include the small
sample size of group 1; there were only 58 patients
in this group prior to our inclusion criteria mandat-
ing evidence of lower-tract inflammation or testing
positive for N. gonorrhoeae or C. trachomatis. As a
result, the 95% confidence interval is fairly wide.
Secondly, the most severe cases of upper-tract in-
fection (e.g., tubo-ovarian abscesses) were ex-
cluded from participation. Thus, our results may
apply to more mild to moderate infection.
In conclusion, the evaluation of the lower geni-
tal tract for inflammation is a necessary component
of a careful evaluation of a women suspected of
having upper genital-tract inflammation. 16 The
evaluation is inexpensive, quick, and provides a
sensitive test for the diagnosis of upper genital-
tract infection. Future studies should evaluate the
diagnostic test characteristics of mucopus and vagi-
nal WBCs compared to other simple and inexpen-
sive tests in large populations with suspected up-
per-tract infection. Only then can we develop ac-
curate diagnostic algorithms that maximize
sensitivity and aid in rapid and accurate diagnosis
and treatment of PID.
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